Objective: This study aimed to verify the effects of a voice therapy program focusing on patients with muscle tension dysphonia (MTD). Patients and Methods: The sample comprised 30 participants diagnosed with MTD, 8 men and 22 women, none of whom was a voice professional. The assessments and reassessments employed the perceptual-auditory protocol GRBASI, measures of maximum phonation times, s/z ratio, and acoustic voice analysis. The voice therapy program included indirect and direct therapy approaches. Results: All parameters assessed using the GRBASI protocol improved following treatment, particularly in regard to lowering voice strain, which is important when treating MTD. The average overall maximum phonation times increased from 8.15 to 10.8 s, while the average s/z ratio did not significantly change. Among the various acoustic parameters, a positive difference was observed for vocal jitter and shimmer. Conclusions: The therapeutic approach adopted in this study proved effective in the treatment of primary and secondary MTD. Speech therapy favored lower phonation effort, lowered vocal strain, and adequacy of adjustment of laryngeal muscles.

Keywords:
Dysphonia, Muscle tension, Rehabilitation, Speech therapy, Laryngeal diseases
1.
Boone DR, McFarlane SC: Functional disorders; in Boone D, McFarlane SC, Von Berg SL, Zraick RI (eds): The Voice and Voice Therapy, ed 9. Boston, Pearson, 2013, pp 113–133.
2.
Van Houtte E, Van Lierde K, Claeys S: Pathophysiology and treatment of muscle tension dysphonia: a review of the current knowledge. J Voice 2011; 25: 202–207.
3.
Van Houtte E, Van Lierde K, D’Haeseleer E, Clayes S: The prevalence of laryngeal pathology in a treatment-seeking population with dysphonia. Laryngoscope 2009; 120: 306–312.
4.
Cielo CA, Christmann MK, Ribeiro VV, Hoffman CF, Padilha JF, Steidl EMS, Bastilha GR, Andriollo DB, Frigo LF: Musculoskeletal stress syndrome, extrinsic laryngeal muscles and body posture: theoretical considerations. Rev CEFAC 2014; 16: 1639–1649.
5.
Van Lierde KM, Bodt M, Dhaeseleer E, Wuyts F, Clayes S: The treatment of muscle tension dysphonia: a comparison of two treatment techniques by means of an objective multiparameter approach. J Voice 2008; 42: 294–301.
6.
Roy N: Functional dysphonia. Curr Opin Otolaryngol Head Neck Surg 2003; 11: 144–148.
7.
Sama A, Carding PN, Price S, Kelly P, Wilson JA: The clinical features of functional dysphonia. Laryngoscope 2001; 111: 458–463.
8.
Altman KW, Atkinson C, Lazarus C: Current and emerging concepts in muscle tension dysphonia: a 30-month review. J Voice 2005; 19: 261–267.
9.
Khodammi SM, Ansari NN, Izadi F, Moghadam ST: The assessment methods of laryngeal muscle activity in muscle tension dysphonia: a review. ScientificWorldJournal 2013; 2013: 1–6.
10.
Lopes LW, Cabral GF, Almeida AAF: Vocal tract discomfort symptoms in patients with different voice disorders. J Voice 2014; 29: 317–323.
11.
Andrade DF, Heuer R, Hockstein NE, Castro E, Spiegel JR, Sataloff RT: The frequency of hard glottal attacks in patients with muscle tension dysphonia, unilateral benign masses and bilateral benign masses. J Voice 1999; 14: 240–246.
12.
Liang F, Yang S, Mei X, Cai Q, Guan Z, Zhang B, Wang Y, Gong J, Huang X, Peng J, Zheng Y: The vocal aerodynamic change in female patients with muscular tension dysphonia after voice training. J Voice 2014; 28: 393.e7–e10.
13.
Watts CR, Diviney SS, Hamilton A, Toles L, Childs L, Mau T: The effect of stretch-and-flow voice therapy on measures of vocal function and handicap. J Voice 2014; 29: 191–199.
14.
Gillispie AI, Gartner-Schmidt J, Rubinstein EN, Abbott KV: Aerodynamic profiles of women with muscle tension dysphonia/aphonia. J Speech Lang Hear Res 2013; 56: 481–488.
15.
Ziegler A, Dastolfo C, Hersan R, Rosen CA, Gartner-Schmidt J: Perceptions of voice therapy in patients diagnosed with primary muscle tension dysphonia and benign mid-membranous vocal folds lesions. J Voice 2014; 28: 742–752.
16.
Brum DM, Cielo CA, Finger LS, Manfrin JA: Considerations regarding vocal and laryngeal modifications caused by vocal fry in women without voice complaints. Rev Soc Bras Fonoaudiol 2010; 15: 282–288.
17.
Behlau M (ed): Voz: O Livro do Especialista. Rio de Janeiro, Revinter, 2005, vol 2.
18.
Ogawa M, Hosokawa K, Yoshida M, Todashi Y, Shiromoto O, Inohara H: Immediate effectiveness of humming on the supraglottic compression in subjects with muscle tension dysphonia. Folia Phoniatr Logop 2013; 65: 123–128.
19.
Cielo CA, Casarin MT: Voiceless fricatives sounds. Rev CEFAC 2008; 10: 352–358.
20.
Mathieson L: The evidence for laryngeal manual therapies in the treatment of muscle tension dysphonia. Curr Opin Otolayngol Head Neck Surg 2011; 19: 171–176.
21.
Mathieson L, Hirani SP, Epstein R, Baken RJ, Wood G, Rubin JS: Laryngeal manual therapy: a preliminary study to examine its treatment effects in the management of muscle tension dysphonia. J Voice 2007; 23: 353–366.
22.
Mota LAA, Santos CMB, Vasconcelos JM, Mota BC, Mota HSC: Applying the technique of sustained maximum phonation time in a female patient with adductor spasmodic dysphonia: a case report. Rev Soc Bras Fonoaudiol 2012; 17: 351–356.
23.
Finger LS, Cielo CA: Reverse phonation – physiologic and clinical aspects of this speech voice therapy modality. Rev Bras Otorrinolaringol 2007; 73: 271–277.
24.
Guzmán M, Callejas C, Castro C, Garía-Campo P, Lavanderos D, Valladares MJ, et al: Therapeutic effect of semi-occluded vocal tract exercises in patients with type I muscle tension dysphonia. Rev Logop Fon Audiol 2012; 32: 139–146.
25.
Hirano M: Clinical Examination of Voice. New York, Springer Verlag, 1981.
26.
Dejonckere PH, Remacle M, Fresnel-Elbaz E, Woisard V, Crevier-Buchman L, Millet B: Differentiated perceptual evaluation of pathological voice quality: reliability and correlations with acoustic measurements. Rev Laryngol Otol Rhinol 1996; 117: 219–224.
27.
Behlau M, Pontes P: Avaliação e Tratamento das Disfonias. São Paulo, Lovise, 1995.
28.
Boone DR, McFarlane SC: Voice therapy; in Boone D, McFarlane SC, Von Berg SL, Zraick RI (eds): The Voice and Voice Therapy, ed 9. Boston, Pearson, 2013, pp 180–246.
29.
Ogawa M, Hosokawa K, Yoshida M, Iwahashi T, Hashimoto M, Inohara H: Immediate effect of humming on computed electroglotographic parameters in patients with muscle tension dysphonia. J Voice 2014; 28: 733–741.
30.
Guzmán M, Laukkanen AM, Krupa P, Horácek J, Svec JG, Geneid A: Vocal tract and glottal function during and after vocal exercising with resonance tube and straw. J Voice 2013; 27: 523.e19–e34.
31.
Carrasco ER, Oliveira G, Behlau M: Vocal perceptual and acoustic analysis of stutterers. Rev CEFAC 2010; 12: 925–935.
32.
Behlau M (ed): Avaliação de voz; in Behlau M (ed): Voz: O Livro do Especialista. Rio de Janeiro, Revinter, 2008, vol 1.
33.
Rubin JS, Lieberman J, Harris TM: Laryngeal manipulation. Otolaryngol Clin North Am 2000; 33: 1017–1034.
34.
Roy N, Leeper HA: Effects of the manual laryngeal musculoskeletal tension reduction technique as a treatment for functional voice disorders: perceptual and acoustic measures. J Voice 1993; 7: 242–249.
35.
Cielo CA, Conterno G, Carvalho CDM, Finger LS: Dysphonias: s/z ratio and types of voice. Rev CEFAC 2008; 10: 536–547.
36.
Van Lierde KM, Clayes S, Bodt M, Cauwenberge P: Long-term outcome of hyperfunctional voice disorders based on a multiparameter approach. J Voice 2007; 21: 179–188.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.